TY - JOUR
T1 - Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM
AU - Klingels, K.
AU - Mayhew, A. G.
AU - Mazzone, Elena Stacy
AU - Duong, T.
AU - Decostre, V.
AU - Werlauff, U.
AU - Vroom, E.
AU - Mercuri, Eugenio Maria
AU - Goemans, N. M.
AU - Eagle, M.
AU - De Groot, I.
AU - Main, M.
AU - Messina, S.
AU - Campion, G.
AU - Servais, L.
AU - Van Den Hauwe, M.
AU - Es, E.
AU - Pane, Marika
AU - Buccella, F.
AU - Kuijer, J.
AU - Ceradini, F.
AU - Henricson, E.
AU - Mcdonald, C.
AU - Florence, J.
PY - 2017
Y1 - 2017
N2 - Aim: To develop a patient-reported outcome measure (PROM) assessing upper limb function related to activities of daily living (ADL) that cannot be observed in a clinical setting, specifically for patients with Duchenne muscular dystrophy (DMD) across a wide age range, applicable in the different stages of the disease. Method: The developmental process was based on US Food and Drug Administration guidelines. This included item generation from a systematic review of existing tools and expert opinion on task difficulty and relevance, involving individuals with DMD. Cultural aspects affecting ADL were taken into consideration to make this tool applicable to the broad DMD community. Items were selected in relation to a conceptual framework reflecting disease progression covering the full range of upper limb function across different ADL domains. Results: After pilot testing and iterative Rasch analyses, redundant or clinically irrelevant items were removed. The final questionnaire consists of 32 items covering four domains of ADL (food, self-care, household and environment, leisure and communication). Test–retest reliability was excellent. Interpretation: A DMD-specific upper limb PROM was developed on the basis of clinical relevance and psychometric robustness. Its main purpose is to document the patient self-reported natural history of DMD and assess the efficacy of interventions.
AB - Aim: To develop a patient-reported outcome measure (PROM) assessing upper limb function related to activities of daily living (ADL) that cannot be observed in a clinical setting, specifically for patients with Duchenne muscular dystrophy (DMD) across a wide age range, applicable in the different stages of the disease. Method: The developmental process was based on US Food and Drug Administration guidelines. This included item generation from a systematic review of existing tools and expert opinion on task difficulty and relevance, involving individuals with DMD. Cultural aspects affecting ADL were taken into consideration to make this tool applicable to the broad DMD community. Items were selected in relation to a conceptual framework reflecting disease progression covering the full range of upper limb function across different ADL domains. Results: After pilot testing and iterative Rasch analyses, redundant or clinically irrelevant items were removed. The final questionnaire consists of 32 items covering four domains of ADL (food, self-care, household and environment, leisure and communication). Test–retest reliability was excellent. Interpretation: A DMD-specific upper limb PROM was developed on the basis of clinical relevance and psychometric robustness. Its main purpose is to document the patient self-reported natural history of DMD and assess the efficacy of interventions.
KW - Duchenne muscular dystrophy
KW - Duchenne muscular dystrophy
UR - http://hdl.handle.net/10807/260283
U2 - 10.1111/dmcn.13277
DO - 10.1111/dmcn.13277
M3 - Article
SN - 0012-1622
VL - 59
SP - 224
EP - 231
JO - Developmental Medicine and Child Neurology
JF - Developmental Medicine and Child Neurology
ER -